Cambridge Investment Research Advisors
USPH icon

Cambridge Investment Research Advisors’s US Physical Therapy USPH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio USPH Stock Details USPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,279
Closed -$270K – 2287
2018
Q3 		$270K Hold
2,279
– – ﹤0.01% 1865
2018
Q2 		$219K Buy
+2,279
New +$211K ﹤0.01% 1953

Other funds holding USPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Cambridge Investment Research Advisors's USPH Position: Q4 2018 in Review

Cambridge Investment Research Advisors sold out of US Physical Therapy (USPH) in Q4 2018, closing a stake of 2,279 shares — an estimated $270K sold.

Cambridge Investment Research Advisors first reported a position in USPH in Q2 2018 and held it in 2 quarters. The position peaked at $270K in Q3 2018. 197 funds tracked by Wall St. Rank hold USPH as of Q4 2018.

  • Cambridge Investment Research Advisors reported no remaining US Physical Therapy position as of Q4 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 2,279 US Physical Therapy shares in Q4 2018, an estimated $270K.
  • Cambridge Investment Research Advisors first reported a position in US Physical Therapy in Q2 2018 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's US Physical Therapy position peaked at $270K in Q3 2018.
  • 197 funds tracked by Wall St. Rank held US Physical Therapy as of Q4 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.